SEC Form 4 · accession 0001193125-26-267739
Jade Biosciences, Inc. · JBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Dobmeier
Director
Period of report
Jun 9, 2026
Accepted (ET)
Jun 11, 2026 · 4:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001798749
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.22 | Jun 9, 2026 | A | 34,843 | A | — | Jun 8, 2036 | Common Stock | 34,843 | 34,843 | D |
Explanation of responses
- F1This option represents a right to purchase shares of the Issuer's common stock, which vests in full on the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continued service to the Issuer.